Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1975 1
1976 2
1977 1
1979 3
1981 1
1982 3
1983 3
1984 2
1985 2
1986 4
1987 6
1988 6
1989 26
1990 17
1991 14
1992 17
1993 25
1994 21
1995 12
1996 17
1997 18
1998 18
1999 15
2000 15
2001 10
2002 19
2003 28
2004 22
2005 31
2006 33
2007 28
2008 20
2009 20
2010 28
2011 48
2012 46
2013 58
2014 52
2015 44
2016 45
2017 60
2018 41
2019 51
2020 45
2021 50
2022 49
2023 45
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

1,027 results

Results by year

Filters applied: . Clear all
Page 1
C3 Glomerulopathy: Pathogenesis and Treatment.
Ahmad SB, Bomback AS. Ahmad SB, et al. Adv Chronic Kidney Dis. 2020 Mar;27(2):104-110. doi: 10.1053/j.ackd.2019.12.003. Adv Chronic Kidney Dis. 2020. PMID: 32553242 Review.
C3 glomerulopathy (C3G) is a rare set of kidney diseases with 2 patterns: C3 glomerulonephritis (C3GN) and dense deposit disease. ...
C3 glomerulopathy (C3G) is a rare set of kidney diseases with 2 patterns: C3 glomerulonephritis (C3GN) and dense deposit disease. ...
Acute glomerulonephritis.
Sethi S, De Vriese AS, Fervenza FC. Sethi S, et al. Lancet. 2022 Apr 23;399(10335):1646-1663. doi: 10.1016/S0140-6736(22)00461-5. Lancet. 2022. PMID: 35461559 Review.
All glomerulonephritis disorders can show periods of exacerbation, but disease flairs characteristically occur in patients with IgA nephropathy or C3 glomerulopathy. The gold standard for the diagnosis of a glomerulonephritis is a kidney biopsy, with a hallmark glomerular …
All glomerulonephritis disorders can show periods of exacerbation, but disease flairs characteristically occur in patients with IgA nephropa …
C3 glomerulopathy - understanding a rare complement-driven renal disease.
Smith RJH, Appel GB, Blom AM, Cook HT, D'Agati VD, Fakhouri F, Fremeaux-Bacchi V, Józsi M, Kavanagh D, Lambris JD, Noris M, Pickering MC, Remuzzi G, de Córdoba SR, Sethi S, Van der Vlag J, Zipfel PF, Nester CM. Smith RJH, et al. Nat Rev Nephrol. 2019 Mar;15(3):129-143. doi: 10.1038/s41581-018-0107-2. Nat Rev Nephrol. 2019. PMID: 30692664 Free PMC article. Review.
The two major subgroups of C3 glomerulopathy - dense deposit disease (DDD) and C3 glomerulonephritis (C3GN) - have overlapping clinical and pathological features suggestive of a disease continuum. Dysregulation of the complement alternative pathway is fundamental to the ma …
The two major subgroups of C3 glomerulopathy - dense deposit disease (DDD) and C3 glomerulonephritis (C3GN) - have overlapping clinic …
Focal Segmental Glomerulosclerosis.
Rosenberg AZ, Kopp JB. Rosenberg AZ, et al. Clin J Am Soc Nephrol. 2017 Mar 7;12(3):502-517. doi: 10.2215/CJN.05960616. Epub 2017 Feb 27. Clin J Am Soc Nephrol. 2017. PMID: 28242845 Free PMC article. Review.
The kidney biopsy can be helpful, with clues provided by features on light microscopy (e.g, glomerular size, histologic variant of FSGS, microcystic tubular changes, and tubular hypertrophy), immunofluorescence (e.g, to rule out other primary glomerulopathies), and electro …
The kidney biopsy can be helpful, with clues provided by features on light microscopy (e.g, glomerular size, histologic variant of FSGS, mic …
C3 glomerulopathy: consensus report.
Pickering MC, D'Agati VD, Nester CM, Smith RJ, Haas M, Appel GB, Alpers CE, Bajema IM, Bedrosian C, Braun M, Doyle M, Fakhouri F, Fervenza FC, Fogo AB, Frémeaux-Bacchi V, Gale DP, Goicoechea de Jorge E, Griffin G, Harris CL, Holers VM, Johnson S, Lavin PJ, Medjeral-Thomas N, Paul Morgan B, Nast CC, Noel LH, Peters DK, Rodríguez de Córdoba S, Servais A, Sethi S, Song WC, Tamburini P, Thurman JM, Zavros M, Cook HT. Pickering MC, et al. Kidney Int. 2013 Dec;84(6):1079-89. doi: 10.1038/ki.2013.377. Epub 2013 Oct 30. Kidney Int. 2013. PMID: 24172683 Free PMC article.
C3 glomerulopathy is a recently introduced pathological entity whose original definition was glomerular pathology characterized by C3 accumulation with absent or scanty immunoglobulin deposition. In August 2012, an invited group of experts (comprising the authors of this d …
C3 glomerulopathy is a recently introduced pathological entity whose original definition was glomerular pathology characterized by C3 …
APOE gene variants in primary dyslipidemia.
Khalil YA, Rabès JP, Boileau C, Varret M. Khalil YA, et al. Atherosclerosis. 2021 Jul;328:11-22. doi: 10.1016/j.atherosclerosis.2021.05.007. Epub 2021 May 23. Atherosclerosis. 2021. PMID: 34058468 Free article. Review.
Several rare APOE gene variants were reported in different types of dyslipidemias including FD, familial combined hyperlipidemia (FCH), lipoprotein glomerulopathy and bona fide autosomal dominant hypercholesterolemia (ADH). ...
Several rare APOE gene variants were reported in different types of dyslipidemias including FD, familial combined hyperlipidemia (FCH), lipo …
Drug-induced nephrotoxicity.
Sales GTM, Foresto RD. Sales GTM, et al. Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s82-s90. doi: 10.1590/1806-9282.66.S1.82. Rev Assoc Med Bras (1992). 2020. PMID: 31939540 Free article. Review.
Nephrotoxicity can be defined as any renal injury caused directly or indirectly by medications, with acute renal failure, tubulopathies, and glomerulopathies as common clinical presentations. Some examples of drugs commonly associated with the acute reduction of glomerular …
Nephrotoxicity can be defined as any renal injury caused directly or indirectly by medications, with acute renal failure, tubulopathies, and …
Complement inhibitors for kidney disease.
Wooden B, Tarragon B, Navarro-Torres M, Bomback AS. Wooden B, et al. Nephrol Dial Transplant. 2023 Nov 8;38(Supplement_2):ii29-ii39. doi: 10.1093/ndt/gfad079. Nephrol Dial Transplant. 2023. PMID: 37218685 Review.
As we increasingly recognize the important role that complement activation across all three pathways-classical, lectin and alternative-plays in glomerular lesions both rare (e.g. C3 glomerulopathy) and common (e.g. immunoglobulin A nephropathy), we can identify avenues for …
As we increasingly recognize the important role that complement activation across all three pathways-classical, lectin and alternative-plays …
IgA nephropathy: A brief review.
Hassler JR. Hassler JR. Semin Diagn Pathol. 2020 May;37(3):143-147. doi: 10.1053/j.semdp.2020.03.001. Epub 2020 Mar 16. Semin Diagn Pathol. 2020. PMID: 32241578 Review.
IgA nephropathy is a lifelong disease that is the most common primary glomerulopathy worldwide. It has a complicated and incompletely understood pathogenesis that is theorized as a four 'hit' process involving an improperly produced IgA. ...
IgA nephropathy is a lifelong disease that is the most common primary glomerulopathy worldwide. It has a complicated and incompletely …
C3 glomerulopathy: Understanding an ultra-rare complement-mediated renal disease.
Heiderscheit AK, Hauer JJ, Smith RJH. Heiderscheit AK, et al. Am J Med Genet C Semin Med Genet. 2022 Sep;190(3):344-357. doi: 10.1002/ajmg.c.31986. Epub 2022 Jun 23. Am J Med Genet C Semin Med Genet. 2022. PMID: 35734939 Free PMC article. Review.
C3 glomerulopathy (C3G) describes a pathologic pattern of injury diagnosed by renal biopsy. ...
C3 glomerulopathy (C3G) describes a pathologic pattern of injury diagnosed by renal biopsy. ...
1,027 results